Cerulenin

erb-b2 receptor tyrosine kinase 2 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24866893 The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells. 2014 1
2 14999148 Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER -2/ neu -overexpressing human breast cancer cells to docetaxel (taxotere). 2004 Mar 5
3 15235125 Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. 2004 Jul 20 1
4 15390078 Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. 2004 Nov 1